US12600703B2 - Farnesyl Dibenzodiazepinone Synthesis Patent

USPTO granted patent US12600703B2 to AMO Pharma Ltd. for synthetic methods of farnesyl dibenzodiazepinone compounds. The patent protects the chemical synthesis processes for these compounds, including the pharmaceutical compound AMO-01.

Affected parties including pharmaceutical companies and researchers developing similar compounds should conduct freedom-to-operate analyses to ensure their activities do not infringe the granted claims. The patent holder now has exclusive rights to practice the disclosed synthesis methods in the United States.